Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
SWOG Cancer Research Network
1,273 participants
Sep 24, 2018
INTERVENTIONAL
Conditions
Summary
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Given PO
Given PO
Given via injection
intravenous
Given PO
Given SC
Receive SC
Receive SC or IM
Given PO
Undergo bilateral orchiectomy
Given PO
Ancillary studies
Standard radiation
Standard surgery
injection
Locations(338)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03678025